Technology Showcase:
Computational Antibody Discovery

02 December 2026 | Online, 14:00 London | 15:00 Paris | 09:00 New York 

SPONSORED BY

Oxford Global Logo Standard

Explore cutting-edge advancements in computational antibody discovery platforms, featuring real-world case studies on AI/ML in antibody engineering

Learn the latest updates on data generation and normalisation to support effective AI integration. Attendees will witness breakthrough tech firsthand, followed by an interactive expert panel exploring practical uses and key challenges.

  • Unlock the Power of AI in Antibody Engineering - Gain insights into how AI and machine learning are transforming antibody discovery, optimisation, and design.
  • Learn from Real-World Case Studies - Explore practical applications of computational platforms and see how industry leaders are leveraging data-driven approaches to accelerate innovation.
  • Stay Ahead with Data-Driven Strategies - Discover best practices for data generation and normalization to enhance the accuracy and effectiveness of AI-powered discovery tools.

This is your chance to see the latest tools in action, understand their real-world impact, and leave with practical takeaways to apply in your own research.

VPs, Directors & Senior Managers from leading pharma & biotech companies and research institutions in the following fields and more:

 

  • Antibody Discovery
  • Bioinformatics
  • Computational Tools
  • Antibody Design
  • Protein Engineering
  • Biologics Discovery

60-Minute Agenda

14:00 – 14:15
Rebecca

Integrating AI into Biologics Discovery

Core elements of augmenting experimental biologics discovery and design workflows with AI &machine learning | Transitioning to an AI-centric biologics drug discovery workflow | Case studies on the impact of AI on pipeline projects
Rebecca
Rebecca Croasdale-Wood
Senior Director Augmented Biologics Design, AstraZeneca
14:15 – 14:30
Norbert Furtmann

Towards Biologics by Design: AI-Powered Protein Design and Optimisation

Transitioning from discovery-driven to design-driven biologics generation: key concepts and applications | Towards de novo design of binding domains | AI-driven optimisation of multi-specific formats
Norbert Furtmann
Norbert Furtmann
Head of Biologics AI & Design, Sanofi
14:30 – 15:00

Panel Discussion: Harnessing AI & Data To Accelerate Biologics Discovery

AI’s impact on biologics discovery over the past five years | Where AI is working well today, and where important limitations remain | The role of data in enabling progress | Challenges associated with increasingly complex biologics | Perspectives on where the field is headed next
All speakers will join the panel discussion.
(Norbert Furtmann, Head of Biologics AI & Design, Sanofi;Rebecca Croasdale-Wood, Senior Director Augmented Biologics Design, AstraZeneca)

Agenda

13:40 – 14:00

Industry Presentation: TACAs: Opening up the Target Space to a New Frontier

PETER SONDERMANN
Chief Executive Officer, Tacalyx
14:00 – 14:20

Industry Presentation: Innovative Strategies For Efficient NK Cell Redirection

LUKAS PEKAR
Lab Head, Merck KGaA
14:20 – 14:40

Solution Provider Presentation

For sponsorship opportunities please contact: sponsorship@oxfordglobal.com
14:40 – 15:00

See The Technology In Action + Live Q&A

15:00

End of Technology Showcase

About Technology Showcases

Our Technology Showcases are interactive, online events that bring together leading experts and innovators to share insights on the latest technology in a specific field.

This series is designed for industry professionals, scientists and researchers to stay ahead of the latest innovations. Each showcase spotlights a critical real-world success story, where leading experts share how cutting-edge technologies are transforming research and overcoming key challenges.

Each showcase features two expert talks from leaders in the field, followed by an in-depth exploration and demonstration of new technologies from our Solution Providers and a live Q&A. Gain practical insights and witness technologies in action.